EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.5.1.115 | (1R,2R,3R,5S)-2,3,5-trihydroxy-5-(hydroxymethyl)cyclohexyl 2-({[3-chloro-4-(propan-2-ylsulfonyl)thiophen-2-yl]carbonyl}amino)-2-deoxy-alpha-D-glucopyranoside | 11% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
3.5.1.115 | (1R,2R,3R,5S)-2,3,5-trihydroxy-5-(hydroxymethyl)cyclohexyl 2-deoxy-2-({[1-(3,5-dichlorophenyl)-5-ethyl-1H-pyrazol-4-yl]carbonyl}amino)-alpha-D-glucopyranoside | 26% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
3.5.1.115 | (1R,2R,3R,5S)-2,3,5-trihydroxy-5-(hydroxymethyl)cyclohexyl 2-deoxy-2-[(4-nitrobenzoyl)amino]-alpha-D-glucopyranoside | 15% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
3.5.1.115 | (1R,2R,3R,5S)-2,3,5-trihydroxy-5-(hydroxymethyl)cyclohexyl 2-deoxy-2-[(furan-2-ylcarbonyl)amino]-alpha-D-glucopyranoside | 15% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
3.5.1.115 | (1R,2R,3R,5S)-2,3,5-trihydroxy-5-(hydroxymethyl)cyclohexyl 2-deoxy-2-[(naphthalen-2-ylcarbonyl)amino]-alpha-D-glucopyranoside | 13% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
3.5.1.115 | (1R,2R,3R,5S)-2,3,5-trihydroxy-5-(hydroxymethyl)cyclohexyl 2-deoxy-2-[(pyridin-4-ylcarbonyl)amino]-alpha-D-glucopyranoside | 46% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
3.5.1.115 | (1R,2R,3R,5S)-2,3,5-trihydroxy-5-(hydroxymethyl)cyclohexyl 2-deoxy-2-[(thiophen-2-ylcarbonyl)amino]-alpha-D-glucopyranoside | 13% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
3.5.1.115 | (1R,2R,3R,5S)-2,3,5-trihydroxy-5-(hydroxymethyl)cyclohexyl 2-deoxy-2-{[3-(propylsulfanyl)benzoyl]amino}-alpha-D-glucopyranoside | less than 10% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
3.5.1.115 | (1R,2R,3R,5S)-2,3,5-trihydroxy-5-(hydroxymethyl)cyclohexyl 2-deoxy-2-{[4-(dimethylamino)benzoyl]amino}-alpha-D-glucopyranoside | 44% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
3.5.1.115 | (1R,2R,3R,5S)-2,3,5-trihydroxy-5-(hydroxymethyl)cyclohexyl 2-deoxy-2-{[4-(trifluoromethyl)benzoyl]amino}-alpha-D-glucopyranoside | 16% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
3.5.1.115 | (1R,2R,3R,5S)-2,3,5-trihydroxy-5-(hydroxymethyl)cyclohexyl 2-[(1-benzothiophen-6-ylcarbonyl)amino]-2-deoxy-alpha-D-glucopyranoside | 15% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
3.5.1.115 | (1R,2R,3R,5S)-2,3,5-trihydroxy-5-(hydroxymethyl)cyclohexyl 2-[(cyclopropylcarbonyl)amino]-2-deoxy-alpha-D-glucopyranoside | 13% inhibition at 0.05 mM | Mycobacterium tuberculosis | |
3.5.1.115 | (1R,2R,3R,5S)-2,3,5-trihydroxy-5-(hydroxymethyl)cyclohexyl 2-[({6-[(4-chlorophenyl)sulfanyl]pyridin-2-yl}carbonyl)amino]-2-deoxy-alpha-D-glucopyranoside | 10% inhibition at 0.05 mM | Mycobacterium tuberculosis |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.1.115 | a mycothiol S-conjugate + H2O | Mycobacterium tuberculosis | - |
an N-acetyl L-cysteine-S-conjugate + 1-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositol | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.5.1.4 | Mycobacterium tuberculosis | - |
- |
- |
3.5.1.115 | Mycobacterium tuberculosis | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.1.4 | mycothiol bimane + H2O | - |
Mycobacterium tuberculosis | ? | - |
? | |
3.5.1.115 | a mycothiol S-conjugate + H2O | - |
Mycobacterium tuberculosis | an N-acetyl L-cysteine-S-conjugate + 1-O-(2-amino-2-deoxy-alpha-D-glucopyranosyl)-1D-myo-inositol | - |
? | |
3.5.1.115 | mycothiol bimane + H2O | - |
Mycobacterium tuberculosis | ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.5.1.4 | mycothiol-S-conjugate amidase | - |
Mycobacterium tuberculosis |
3.5.1.115 | MCA | - |
Mycobacterium tuberculosis |